Use of a fluorescent imaging plate reader-based calcium assay to assess pharmacological differences between the human and rat vanilloid receptor

Journal of Biomolecular Screening

Volumn 7, Issue 5, 2002, Pages 466-475

  Witte, David G ^a   Cassar, Steven C ^a   Masters, Jeffrey N ^a   Esbenshade, Timothy ^a   Hancock, Arthur A ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CAPSAICIN; CAPSAZEPINE; DITERPENE; DRUG DERIVATIVE; DRUG RECEPTOR; LIGAND; RESINIFERATOXIN; RUTHENIUM RED; TINYATOXIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BIOASSAY; CELL CULTURE; COMPARATIVE STUDY; DRUG EFFECT; FLUORESCENCE; GENETICS; HUMAN; INSTRUMENTATION; KINETICS; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; RAT; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL ASSAY; CALCIUM; CAPSAICIN; CELLS, CULTURED; DITERPENES; FLUORESCENCE; HUMANS; KINETICS; LIGANDS; MOLECULAR SEQUENCE DATA; RATS; RECEPTORS, DRUG; RUTHENIUM RED; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY;

EID: 0642308614     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1177/108705702237679     Document Type: Article

References (22)

1. Caterina MJ, Rosen M, Tominaga AJ, Brake D, Julius A:A capsaicin-receptor homologue with a high threshold for noxious heat. Nature 1999;398:436-441.
2. Guo A, Vulchanova L, Wang J, Li X, Eide R: Immunocytochemical localization of the vanilloid receptor l (VR1): relationship to neuropeptides, the P2X purinoceptorand IB4 binding sites. Eur J Neurosci 1999;11:946-958.
3. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D: The capsaicin receptor, a heat-activated ion channel in the pain pathway. Nature 1997;389:816-824.
4. Hayes P, Meadows HJ, Gunthorpe MJ, Harries MH, Duckworth MD, Caims W, et al: Cloning and functional expression of a human orthologue of rat vanilloid receptor-1. Pain 2000;88:205-215.
5. Tominaga M, Caterina MJ, Malberg AB, Rosen TA, Gilbert H, Skinner K, et al: The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998;21:531-543.
6. Ichikawa H, Sugimoto T: VR1 -immunoreactive primary sensory neurons in the rat trigeminal ganglion. Brain Res 2000;890:184-188.
7. Yaksh TL, Färb DH, Leeman SE, Jessell TM: Intrathecal capsaicin depletes substance P in the rat spinal chord and produces prolonged thermal analgesia. Science 1979;206:48M83.
8. Robbins WR, Staats PS, Levine J, Fields HL, Alien RW, Campbell JN, et al: Treatment of intractable pain with topical large-dose capsaicin: preliminary report. Anesth Analg 1998;86(3):579-583.
9. Fusco BM, Giacovazzo M: Peppers and pain: the promise of capsaicin. Drugs 1997;53(6):909-914.
10. Catarina MJ, Leffler A, Malberg AB, Martin WJ, Trafton J, PeterscnZeitz KR, et al: Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000;288:306-313.
11. Szallasi A, Blumberg PM: Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 1999;51(2):159-211.
12. Bevan SJ, Holhi S, Hughes G, James IF, Rang HP, Shah K, et al: a competitive antagonist of the sensory neuron excitant capsaicin. Br J Pharmacol 1992;107:544-552.
13. Dray A, Forbes CA, Burgess GM: Ruthenium red blocks the capsaicininduced increase in intracellular calcium and activation of membrane currents in sensory neurons as well as the activation of peripheral nociceptors in vitro. Neurosci Lett 1990;110:52-59.
14. Miller TR, Witte DG, Ireland LM, Kang CH, Roch JM, Masters JN, et al: Analysis of apparent noncompetitive responses to competitive HI -histamine receptor antagonists in fluorescent imaging plate reader-based calcium assays. J Biomolec Screening 1999;4(5):249-258.
15. Kuntzweiler TA, Arneric SP, Donnelly-Roberts DL: Rapid assessment of ligand actions with nicotinic acetylcholine receptors using calcium dynamics and FL1PR. Drug Dev Res 1998;44:14-20.
16. Jerman JC, Brough SJ, Prinjha R, Harries HH, Davis JB, Smart D: Characterization using FL1PR of rat vanilloid receptor (rVRl) pharmacology. Br J Pharmacol 2000; 130:916-922.
17. Smart D, Jerman JC,GunthorpeMJ,BroughSJ,RansonJ, Cairns W, et al: Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology. Eur J Pharmacol 2001; 417:51-58.
18. Zygmunt PM, Petersson J, Andersson DA, Chuang HH, Sorgärd M, Di Marzo V, et al: Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999;400:452-457.
19. Dickenson AH, Dray A: Selective antagonism of capsaicin by capsazepine: evidence for a spinal receptor site in capsaicin-induced antinociception. Br J Pharmacol 1991;104(4):1045-1049.
20. Kedei N, Szabo T, Lite JD, Olah Z, ladarola MJ, Blumberg PM: Analysis of the quarternary structure of vanilloid receptor I. J Biol Chem 2001:276:28613-28619.
21. Mclntyre P, McLatchie LM, Chambers A, Phillips E, Clarke M, Savidge J, et al: Pharmacological differences between the human and rat vanilloid receptor l (VR1). BrJ Pharmacol 2001:132:1084-1094.
22. Chu KL, McDonald HA, Cassar S, Witte D, Masters J, Vos M, et al: Pharmacological comparison of recombinant human and rat VR1 receptors [Poster 910.1]. Paper presented at the 31st annual meeting of the Society for Neurosciences, San Diego, CA; November, 2001.